🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Trajectories of kidney function in diabetes go.nature.com/3iqUjuo

Our Transfusion Medicine Fellowship is now accepting applications! #transfusionmedicine #pathology #path2path #PathTwitter #pathfellowship #whyucla Apply Now! 👉 bit.ly/3P1DeoB 👉 bit.ly/44SnsVI

Fibrillary GN can show apparent light chain restriction (lambda here). Pronase IF reveals unmasked kappa staining. DNAJB9 +. Not an uncommon finding in fibrillary GN (PMID: 32622524). Not MGRS. Also showed TBM DNAJB9 deposits often seen with fibrillary GN. #renalpath #pathtwitter

Applications for the GlomCon "Glomerular Disease Fellowship" are now open! Find out more at: glomcon.org/apply

This Sunday! #renalpath Renal Pathology Society Mayo Clinic Nephrology Mayo Clinic Pathology

Join GlomCon and Renal Pathology Society this Sunday: Treatment Resistant T-Cell–Mediated Rejection by Dr. Shana Coley ID: 875 5077 1266 Passcode 202122 sign up 👉🏻 bit.ly/signup-glomcon #GlomCon

Join GlomCon and Renal Pathology Society this Sunday for a talk on: Alport Spectrum Disorders by Dr. Danica Galesic Ljubanovic via ZOOM ID: 875 5077 1266 Passcode 202122 sign up 👉🏻bit.ly/signup-glomcon #GlomCon

Alport Spectrum Disorders, are due the mutation of the genes for: A5 - X linked A3, A4 - autosomal diseases 🧬 Glomerular basement membrane are formed by type 4 collagen. 🧵There are 6 different alpha chains. A1 to A6. Renal Pathology Society GlomCon

Our Mayo Clinic Membranous Nephropathy Consensus Report is finally out. A year in the making. The manuscript brings together the recent advances in MN. I am very thankful to all my collaborators. Mayo Clinic Nephrology Mayo Clinic Mayo Clinic Pathology sciencedirect.com/science/articl…

Join Glomcon and Renal Pathology Society this Sunday: AI in Renal Pathology by Dr. Kuang-Yu Jen ID: 875 5077 1266 Passcode 202122 sign up 👉🏻 bit.ly/signup-glomcon

Great webinar with Kuang-Yu Jen, MD, PhD last Sunday!

Contribute your ideas! We welcome input from any interested parties regarding ethics of #xenotransplantation , to be considered at American Society of Transplantation (AST) Controversies Conf in 2024. 5 questions in online form: bit.ly/xenoethics Alton Brad Farris Kim Solez @ElisaJGordon @LSydMJohnson

FYI us.elsevierhealth.com/diagnostic-pat…

Join Glomcon and Renal Pathology Society this Sunday: Banff 2022: An Update by Dr. Candice Roufosse ID: 875 5077 1266 Passcode 202122 sign up 👉🏻 my.glomcon.org #GlomCon

Just in time for Thanksgiving in the USA 🦃, Dr. Anna Kottgen and I are delighted to share our new study in Kidney Intl.: "Multi-omic analysis of human kidney tissue identified medulla-specific gene expression patterns". A 🧵 to whet your appetite (1/14) doi.org/10.1016/j.kint…

Looking forward to participating in the Renal Pathology Society companion mtg on March 24 at #USCAP2024 in Baltimore USCAP, especially the warmer temps and longer days.....and Fadi Salem, M.D. (our 1st #renalpath fellow) 2024am.uscap.org/schedule/

Join GlomCon and Renal Pathology Society this Sunday Computational pathology of FSGS and MCD by Dr. Laura Barisoni ID: 875 5077 1266 Passcode 202122 sign up 👉🏻 bit.ly/signup-glomcon #GlomCon

It gives me great pleasure to announce the Call for Abstracts for the combined UltraPath XXI Conference and Electron Microscopy Tutorial Day to be held from Monday Sep 30 to Friday Oct 4, 2024, in Sydney Australia. We hope to see you in Sydney! #callforpapers #electronmicroscopy

Clinicopathologic Characteristics, Etiologies, and Outcome of Secondary Oxalate Nephropathy - Mayo Clinic Proceedings mayoclinicproceedings.org/article/S0025-… Mayo Clinic Pathology Mayo Clinic Nephrology Renal Pathology Society #renalpath

"Clinical Nephrology Insights" Review in #ASNJASN discusses the progress in discovering autoantigens in membranous nephropathy, highlighting the importance of considering the varying strength of association between certain antigens and underlying conditions.